Johnson & Johnson Announces $2 Billion Investment in New Manufacturing Facility

(Reuters) – Johnson & Johnson announced on Tuesday that it will invest over $2 billion to build a new manufacturing facility in Wilson, North Carolina, which will boost the production of new therapies.

The new facility is set to expand J&J’s production of biologic medications used to treat cancer, immunity-related issues, and neurological diseases.

The drugmaker aims to launch or file for more than 70 new therapies and expanded treatment options for patients by 2030.

J&J is investing in capacity to ensure a resilient supply chain for the future, according to Dapo Ajayi, vice president at J&J’s innovative medicine supply chain.

The company expects construction to begin in the first half of 2025 and will create approximately 400 full-time jobs once the facility is fully operational.